A carregar...
Current advances of targeting epigenetic modifications in neuroendocrine prostate cancer
Neuroendocrine prostate cancer (NEPC) is the most lethal malignancy of prostate cancer (PCa). Treatment with next-generation androgen receptor (AR) pathway inhibitors (ARPIs) has successfully extended patients' lifespan. However, with the emergence of drug resistance, PCa tumors increasingly ad...
Na minha lista:
| Publicado no: | Tzu Chi Med J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer - Medknow
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8323647/ https://ncbi.nlm.nih.gov/pubmed/34386358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tcmj.tcmj_220_20 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|